Case File
efta-efta00848737DOJ Data Set 9OtherFrom: "Jeffrey E." <jeevacation®gmail.com>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00848737
Pages
3
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: "Jeffrey E." <jeevacation®gmail.com>
To: G Sera
Subject: Fwd: Can you please call me when you can?
Date: Fri, 14 Aug 2015 03:54:35 +0000
Attachments: bdg_2014_V5_WITH_2DAY.xls; Nologo_2014_-_V5.xlsx
???
Forwarded message
From: G Sera <I
Date: Thu, Feb 27, 2014 at 7:50 AM
Subject: Re: Can you please call me when you can?
To: Jeffrey Epstein <[email protected]>
Jeff, here are the numbers of 2morrow and 2day. This is the cash flow I review monthly and what I use to keep
operations under control. Cash flow is much better than accounting for this purpuse as a properly run modeling
operation does not generate long term payables (we pay the models immediately after teh job). I quickly put the
lablels in english please let me know if anything is not clear. 2day was launched a little over 1 year ago and will
be cashflow positive in approx 6 months.
I then am sending a second file for NologoMGMT (former Future). This is separate because there is another GM
there (Mauro instead of Giancarlo). The company was launched only 18 months ago and is cash-flow positive as
you can see.
G
On Thu, Feb 27, 2014 at 11:51 AM, Jeffrey Epstein <[email protected]> wrote:
can you send me the numbers for 2 morrow 2day etc. .
On Wed, Feb 26, 2014 at 6:42 PM, G Sera < wrote:
When you want.
Thank you for your guidance
On Wednesday, February 26, 2014, Jeffrey Epstein <[email protected]> wrote:
Talk this weekend
On Wednesday, February 26, 2014, G Sera < wrote:
I agree but they ask me to commit to a 3 year time. I am sure they will put some good money behind the
commitment but that's nt the point. The low risk solution for me is to take position and keep the rest on
the side, but you are very smart and experienced and I value your input.
I never like to feel like I have to do anything, even if it's a great opportunity and a step up. I am built
like that.
I very much appreciate your thoughts.
PROT0
G
On Wednesday, February 26, 2014, Jeffrey Epstein <[email protected]> wrote:
what would you Ike to do. why not take the new position , at least for awhile. " no downside,
otherwise present me a biz plan
On Wed, Feb 26, 2014 at 4:18 PM, G Sera < wrote:
Thank you
Thank you
Gianni
[REDACTED]*****************************************
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
The information contained in this communication is
PROT1
confidential, may be attorney-client privileged, may constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved please note
The information contained in this communication is confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for the use of the addressee. It is the property of
JEE
Unauthorized use, disclosure or copying of this communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
PROT2
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.